Serum Bilirubin - Total & Direct

Liver

Report in 4Hrs

At Home

No Fasting Required

Details

Breakdown product of hemoglobin; elevated in liver disease or hemolysis, causing jaundice.

₹89₹275

68% OFF

Serum Bilirubin - Total & Direct: Comprehensive Test Information Guide

Why is it done?
- Test Purpose: Measures the levels of total bilirubin and direct (conjugated) bilirubin in the blood to assess liver function and detect abnormalities in bile processing and hemoglobin metabolism.
- Primary Indications: Evaluation of jaundice or yellowing of skin and eyes, assessment of liver disease, investigation of hemolytic anemia, monitoring of bile duct obstruction, and evaluation of unexplained abdominal pain.
- Common Clinical Scenarios: Routine liver function panel screening, evaluation of acute hepatitis, monitoring chronic liver disease, assessment of neonatal jaundice, investigation of suspected gallstones or pancreatic disease, and monitoring response to treatment in hepatic disorders.
- Timing: Performed when patients present with clinical signs of jaundice, in annual health checkups, during initial assessment of liver disease, and as part of comprehensive metabolic panel or liver function tests.
Normal Range
- Total Bilirubin: 0.1 - 1.2 mg/dL (1.7 - 20.5 µmol/L) in adults; newborns may have slightly higher values up to 15 mg/dL in first few days of life.
- Direct (Conjugated) Bilirubin: 0.0 - 0.3 mg/dL (0 - 5.1 µmol/L) in adults; typically comprises less than 20% of total bilirubin.
- Indirect Bilirubin: Calculated as Total minus Direct; normal range 0.1 - 0.9 mg/dL (1.7 - 15.4 µmol/L).
- Units of Measurement: Measured in milligrams per deciliter (mg/dL) or micromoles per liter (µmol/L); conversion factor is 1 mg/dL = 17.1 µmol/L.
- Result Interpretation: Normal = all values within reference ranges; Low = below normal range (rare, usually not clinically significant); Mildly elevated = 1.3 - 2.5 mg/dL (borderline); Moderately elevated = 2.6 - 5.0 mg/dL (abnormal); Significantly elevated = >5.0 mg/dL (requires investigation).
- What Normal Means: Liver is functioning properly, adequate bile flow, normal hemoglobin metabolism, and no obstruction of bile ducts.
Interpretation
- Elevated Total Bilirubin (>1.2 mg/dL): Indicates impaired liver function or increased red blood cell breakdown; requires differentiation between conjugated and unconjugated hyperbilirubinemia.
- Predominantly Elevated Direct Bilirubin (>0.3 mg/dL): Suggests cholestasis (bile duct obstruction or hepatocellular injury with excretory dysfunction); indicates liver has conjugated bilirubin but cannot excrete it properly; associated with cirrhosis, hepatitis, gallstones, or pancreatitis.
- Predominantly Elevated Indirect Bilirubin (>0.9 mg/dL): Suggests hemolysis (excessive red blood cell destruction), impaired hepatic uptake/conjugation, or genetic disorders like Gilbert's syndrome; indicates problem occurring before or during bilirubin conjugation.
- Mildly Elevated Results (1.3 - 2.5 mg/dL): May be borderline or require repeat testing; could indicate early liver disease, mild hemolysis, or subclinical jaundice; clinical context is essential for interpretation.
- Significantly Elevated Results (>5.0 mg/dL): Clinically significant jaundice; visible jaundice typically appears when total bilirubin exceeds 2.5 - 3 mg/dL; suggests severe liver disease, significant hemolysis, or complete bile duct obstruction.
- Factors Affecting Results: Hemolysis during blood draw, medications (oral contraceptives, steroids, antibiotics), sunlight exposure (phototherapy), diet, exercise, dehydration, pregnancy, and certain genetic conditions.
- Pattern Recognition: Analyze the ratio and pattern of direct to indirect bilirubin; predominantly direct elevation suggests post-hepatic or hepatic cholestasis; predominantly indirect suggests pre-hepatic or early hepatic disease.
Associated Organs
- Primary Organ System: Hepatobiliary system including liver, gallbladder, bile ducts, and pancreas; also relates to hematopoietic system (blood production and destruction).
- Liver Disease: Acute hepatitis, chronic hepatitis B or C, alcoholic liver disease, cirrhosis, fatty liver disease (NAFLD), autoimmune hepatitis, hemochromatosis, Wilson's disease, and primary biliary cholangitis.
- Biliary System Disease: Gallstones (choledocholithiasis), bile duct obstruction, biliary strictures, cholangitis (bile duct infection), and gallbladder dysfunction.
- Hemolytic Disorders: Autoimmune hemolytic anemia, sickle cell disease, hereditary spherocytosis, G6PD deficiency, transfusion reactions, and hypersplenism.
- Pancreatic Disease: Acute or chronic pancreatitis causing bile duct compression or obstruction of pancreatic duct.
- Genetic Disorders: Gilbert's syndrome (most common benign hereditary condition), Crigler-Najjar syndrome, Dubin-Johnson syndrome, and Rotor syndrome.
- Complications Associated with Elevated Bilirubin: Kernicterus (in severe neonatal hyperbilirubinemia), hepatic encephalopathy in cirrhosis, portal hypertension, ascites, variceal bleeding, and acute liver failure if severely elevated.
- Neonatal Considerations: Physiologic jaundice in newborns, hemolytic disease of the newborn (Rh incompatibility, ABO incompatibility), and neonatal hepatitis.
Follow-up Tests
- Liver Function Tests (LFTs): Alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT) to assess degree of hepatocellular injury or cholestasis.
- Complete Blood Count (CBC): Evaluates hemoglobin, hematocrit, and red blood cell indices to assess for hemolytic anemia or other blood disorders causing elevated bilirubin.
- Reticulocyte Count: Elevated reticulocyte count indicates hemolysis; helps differentiate hemolytic causes of hyperbilirubinemia.
- Lactate Dehydrogenase (LDH) and Haptoglobin: LDH elevated in hemolysis; haptoglobin low in hemolytic anemia; useful markers to confirm hemolysis as cause.
- Imaging Studies: Abdominal ultrasound (initial choice for bile duct obstruction and gallstones), CT or MRCP if ultrasound inconclusive, and abdominal imaging to assess for liver cirrhosis or mass lesions.
- Viral Serology: Hepatitis A, B, and C serologies if viral hepatitis suspected; useful in acute hepatitis presentation.
- Prothrombin Time (PT/INR): Assesses liver synthetic function; prolonged PT indicates advanced liver disease or severe hepatic dysfunction.
- Albumin and Total Protein: Low albumin indicates chronic liver disease; useful for assessing liver synthetic function and severity.
- Autoimmune Markers: Antinuclear antibody (ANA), anti-smooth muscle antibody if autoimmune hepatitis suspected.
- Monitoring Frequency: For chronic liver disease: repeat every 3-6 months; for acute hepatitis: repeat every 2-4 weeks until normalization; for Gilbert's syndrome: no routine monitoring needed.
- Liver Biopsy: May be indicated if diagnosis remains uncertain after non-invasive testing, to assess degree of fibrosis or cirrhosis in chronic liver disease.
Fasting Required?
- Fasting Requirement: NO - Serum bilirubin testing does not require fasting. This test can be performed at any time of day without dietary restrictions.
- Food and Beverage: Regular food and beverages, including coffee and water, can be consumed before the test. Bilirubin levels are not significantly affected by recent meals.
- Medications: Medications should be taken as normally prescribed unless specifically instructed otherwise by physician. Some medications (antibiotics, oral contraceptives, corticosteroids) may affect bilirubin levels but should not be withheld without medical guidance.
- Timing Considerations: Early morning collection is preferred to maintain laboratory consistency, though not strictly necessary. Bilirubin levels may fluctuate slightly throughout the day due to natural circadian rhythms.
- Specimen Collection: Venipuncture (blood draw) from arm; protect sample from prolonged light exposure as bilirubin degrades in sunlight (photodegradation). Sample should be transported promptly to laboratory.
- Special Preparations: Comfortable clothing with easily accessible arm for venipuncture is recommended. If anxious about blood draws, inform phlebotomist. Stay hydrated but avoid excessive fluid intake just before test.
- Pre-test Instructions: Avoid strenuous exercise immediately before test as this may temporarily affect results. Inform healthcare provider of all current medications and supplements. Alcohol consumption should be minimized for 24 hours before test, especially if liver disease is suspected.

How our test process works!